<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: The causal nature of associations between circulating <z:chebi fb="4" ids="17855">triglycerides</z:chebi>, <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> is unclear </plain></SENT>
<SENT sid="1" pm="."><plain>We aimed to use Mendelian randomization to test the hypothesis that raised circulating <z:chebi fb="0" ids="17855">triglyceride</z:chebi> levels causally influence the risk of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and raise <z:mpath ids='MPATH_458'>normal</z:mpath> fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> levels and hepatic <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>RESEARCH DESIGN AND METHODS: We tested 10 common genetic variants robustly associated with circulating <z:chebi fb="0" ids="17855">triglyceride</z:chebi> levels against the type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> status in 5,637 case and 6,860 control subjects and four continuous outcomes (reflecting glycemia and hepatic <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>) in 8,271 nondiabetic individuals from four studies </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Individuals carrying greater numbers of <z:chebi fb="0" ids="17855">triglyceride</z:chebi>-raising alleles had <z:mp ids='MP_0001552'>increased circulating triglyceride levels</z:mp> (SD 0.59 [95% CI 0.52-0.65] difference between the 20% of individuals with the most alleles and the 20% with the fewest alleles) </plain></SENT>
<SENT sid="4" pm="."><plain>There was no evidence that the carriers of greater numbers of <z:chebi fb="0" ids="17855">triglyceride</z:chebi>-raising alleles were at increased risk of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (per weighted allele odds ratio [OR] 0.99 [95% CI 0.97-1.01]; P = 0.26) </plain></SENT>
<SENT sid="5" pm="."><plain>In nondiabetic individuals, there was no evidence that carriers of greater numbers of <z:chebi fb="0" ids="17855">triglyceride</z:chebi>-raising alleles had increased fasting insulin levels (SD 0.00 per weighted allele [95% CI -0.01 to 0.02]; P = 0.72) or increased fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> levels (0.00 [-0.01 to 0.01]; P = 0.88) </plain></SENT>
<SENT sid="6" pm="."><plain>Instrumental variable analyses confirmed that genetically raised circulating <z:chebi fb="0" ids="17855">triglyceride</z:chebi> levels were not associated with increased <z:mp ids='MP_0002055'>diabetes</z:mp> risk, fasting <z:chebi fb="105" ids="17234">glucose</z:chebi>, or fasting insulin and, for <z:mp ids='MP_0002055'>diabetes</z:mp>, showed a trend toward a protective association (OR per 1-SD increase in log(10) <z:chebi fb="4" ids="17855">triglycerides</z:chebi>: 0.61 [95% CI 0.45-0.83]; P = 0.002) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: Genetically raised circulating <z:chebi fb="0" ids="17855">triglyceride</z:chebi> levels do not increase the risk of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> or raise fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> or fasting insulin levels in nondiabetic individuals </plain></SENT>
<SENT sid="8" pm="."><plain>One explanation for our results is that raised circulating <z:chebi fb="4" ids="17855">triglycerides</z:chebi> are predominantly secondary to the <z:mp ids='MP_0002055'>diabetes</z:mp> disease process rather than causal </plain></SENT>
</text></document>